discontinue sulfonylurea when starting glp-1 receptor agonist 💬 Perspective by Daniel Lieberman, PhD, Daniel Aslan, PhD, and Steven Heymsfield, MD: Although #GLP-1 agonists have transformed #pharmacologic approaches to #obesity, most patients use within one year and are 💉 GLP-1 vs GLP-1/GIP: semaglutide Flavor:Blood Orange

discontinue sulfonylurea when starting glp-1 receptor agonist 💬 Perspective by Daniel Lieberman, PhD, Daniel Aslan, PhD, and Steven Heymsfield, MD: Although #GLP-1 agonists have transformed #pharmacologic approaches to #obesity, most patients use within one year and are 💉 GLP-1 vs GLP-1/GIP: semaglutide Flavor:Blood Orange

💉 GLP-1 vs GLP-1/GIP: What's the Difference? You've probably heard about Semaglutide and Tirzepatide — two popular options for medical weight loss — but what actually sets them apart? 🤔 ✨ Semaglutide (

The authors concluded, "Treatment with GLP-1 receptor agonists was associated with lower all-cause mortality among patients with type 2 diabetes, advanced-stage CKD, and ESKD than was treatment with DPP-4 inhibitors

semaglutide

Flavor:Blood Orange

A research article about the dose–response effects of survodutide, a dual agonist of the subcutaneous glucagon receptor and glucagon-like peptide- 1 receptor, on bodyweight loss and HbA1c levels